Found: 23
Select item for more details and to access through your institution.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 4, p. 229, doi. 10.1177/1756285610374117
- By:
- Publication type:
- Article
The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 817, doi. 10.1177/13524585211035333
- By:
- Publication type:
- Article
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 11, p. 1469, doi. 10.1177/1352458517723718
- By:
- Publication type:
- Article
Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1405, doi. 10.1177/1352458516680749
- By:
- Publication type:
- Article
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 1, p. 94, doi. 10.1177/1352458516638941
- By:
- Publication type:
- Article
Fatigue and fluid hydration status in multiple sclerosis: A hypothesis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 11, p. 1438, doi. 10.1177/1352458516663854
- By:
- Publication type:
- Article
Gait Speed Trajectory During the Six-Minute Walk Test in Multiple Sclerosis: A Measure of Walking Endurance.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.698599
- By:
- Publication type:
- Article
Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0228617
- By:
- Publication type:
- Article
Body mass index trajectories in pediatric multiple sclerosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 2, p. 1, doi. 10.1177/2055217319846141
- By:
- Publication type:
- Article
Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 2, p. 1, doi. 10.1177/2055217318783766
- By:
- Publication type:
- Article
Addressing the targeting range of the ABILHAND-56 in relapsing–remitting multiple sclerosis: A mixed methods psychometric study.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 2, p. 1, doi. 10.1177/2055217318776990
- By:
- Publication type:
- Article
Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0073247
- By:
- Publication type:
- Article
Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosis.
- Published in:
- BMC Neurology, 2012, v. 12, n. 1, p. 1, doi. 10.1186/1471-2377-12-6
- By:
- Publication type:
- Article
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 1, p. 48, doi. 10.1001/jamaneurol.2020.2950
- By:
- Publication type:
- Article
Smoking Beyond Multiple Sclerosis Diagnosis.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 10, p. 1105, doi. 10.1001/jamaneurol.2015.1805
- By:
- Publication type:
- Article
Progression risk stratification with six-minute walk gait speed trajectory in multiple sclerosis.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1259413
- By:
- Publication type:
- Article
Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic.
- Published in:
- International Journal of MS Care, 2021, v. 23, n. 5, p. 234, doi. 10.7224/1537-2073.2021-034
- By:
- Publication type:
- Article
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Real-life walking impairment in multiple sclerosis: preliminary comparison of four methods for processing accelerometry data.
- Published in:
- Multiple Sclerosis (13524585), 2010, v. 16, n. 7, p. 868, doi. 10.1177/1352458510373111
- By:
- Publication type:
- Article
Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
- Published in:
- Multiple Sclerosis (13524585), 2008, v. 14, n. 3, p. 383, doi. 10.1177/1352458507082607
- By:
- Publication type:
- Article
Misdiagnosis of Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2003, v. 43, n. 1, p. 85, doi. 10.1046/j.1526-4610.2003.03019.x
- By:
- Publication type:
- Article